Data as of Mar 14
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 3.50, with a high estimate of 3.75 and a low estimate of 2.00. The median estimate represents a +41.70% increase from the last price of 2.47.
The current consensus among 3 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.